Clinical trial
Thiol-disulfide Homeostasis in Patients With Ovarian Cancer
NCT05011539 is registered in ClinicalTrials.gov with Tepecik Training and Research Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Thiol-disulfide Homeostasis in Patients With Ovarian Cancer
- Lead sponsor
- Tepecik Training and Research Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 9, 2021
- Completion date
- May 1, 2022
- Enrollment
- 115 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
ovarian cancer